Create Free Account

By creating account you will get access to hot stocks & personalised emails

Vita Life Sciences Ltd

Healthcare AU VLS

1.91AUD
-0.01(0.52%)

Last update at 2024-12-12T00:01:00Z

Day Range

1.911.91
LowHigh

52 Week Range

1.542.46
LowHigh

Fundamentals

  • Previous Close 1.92
  • Market Cap110.77M
  • Volume13884
  • P/E Ratio11.59
  • Dividend Yield3.55%
  • EBITDA12.31M
  • Revenue TTM79.17M
  • Revenue Per Share TTM1.46
  • Gross Profit TTM 39.74M
  • Diluted EPS TTM0.17

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 10.74M 11.20M 8.16M 4.43M 4.33M
Minority interest -0.25700M 0.04M -0.27800M -0.06500M 0.03M
Net income 7.08M 8.29M 6.09M 3.14M 2.44M
Selling general administrative 16.69M 14.65M 14.01M 14.67M 13.47M
Selling and marketing expenses 10.42M 7.57M 6.16M 7.38M 6.74M
Gross profit 39.74M 34.81M 29.27M 27.90M 27.64M
Reconciled depreciation 0.60M 0.41M 0.55M 0.60M 0.40M
Ebit 10.77M 11.31M 8.32M 4.57M 4.46M
Ebitda 11.37M 11.71M 8.88M 5.18M 4.87M
Depreciation and amortization 0.60M 0.41M 0.55M 0.60M 0.40M
Non operating income net other - - - - -
Operating income 10.77M 11.31M 8.32M 4.57M 6.08M
Other operating expenses 56.17M 46.09M 38.94M 38.34M 35.08M
Interest expense 0.03M 0.10M 0.17M 0.15M 0.13M
Tax provision 3.40M 2.95M 2.30M 1.33M 1.90M
Interest income 0.13M 0.08M 0.19M 0.02M 0.02M
Net interest income 0.10M 0.04M 0.03M -0.01500M -0.02100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.40M 2.95M 2.30M 1.33M 1.90M
Total revenue 66.89M 57.10M 46.48M 42.45M 41.15M
Total operating expenses 29.02M 23.80M 21.73M 23.79M 21.57M
Cost of revenue 27.15M 22.29M 17.21M 14.55M 13.51M
Total other income expense net -0.03400M -0.10500M -0.16600M -0.14600M -1.74600M
Discontinued operations - - - - -
Net income from continuing ops 7.34M 8.25M 5.86M 3.09M 2.43M
Net income applicable to common shares 7.08M 8.29M 6.09M 3.14M 2.44M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 59.81M 51.80M 45.27M 39.10M 36.51M
Intangible assets - 0.01000M 0.00000M 0.01M 0.01M
Earning assets - - - - -
Other current assets 1.29M 0.47M 0.31M 0.25M 0.26M
Total liab 16.48M 15.30M 14.85M 14.66M 13.98M
Total stockholder equity 43.40M 36.57M 30.75M 24.72M 22.60M
Deferred long term liab - - - 0.01M 0.01M
Other current liab 6.33M 10.06M 3.52M 4.03M 4.58M
Common stock 42.57M 41.90M 41.63M 41.59M 42.25M
Capital stock - 41.90M 41.63M 41.59M 42.25M
Retained earnings -2.76900M -8.48200M -12.52800M -17.92500M -22.04600M
Other liab - 0.14M 0.20M 0.17M 0.16M
Good will - - - - -
Other assets - 2.16M 1.90M 1.54M 1.61M
Cash 24.63M 15.69M 15.89M 14.48M 10.48M
Cash and equivalents - - - - -
Total current liabilities 16.22M 14.86M 14.46M 13.04M 12.12M
Current deferred revenue 4.09M - 6.94M 5.31M 4.37M
Net debt -24.24300M -15.08700M -15.52000M -12.40500M -8.12900M
Short term debt 0.21M 0.30M 0.19M 0.62M 0.64M
Short long term debt - - - 0.34M 0.36M
Short long term debt total 0.39M